Robert B
Healthcare
Targovax
Norway
Biography
PhD, Chairman at Haemostatix. Extensive experience in building biotechnology companies, previously as the CEO of 4-Antibody AG, Affitech (NASDAQ/OMX), and Celldex Therapeutics (NASDAQ). Prior to Celldex, Robert was Director of Technology Licensing at the Ludwig Institute for Cancer Research, a leading independent research organisation conducting translational research in cancer immunology. PhD, Chairman at Haemostatix. Extensive experience in building biotechnology companies, previously as the CEO of 4-Antibody AG, Affitech (NASDAQ/OMX), and Celldex Therapeutics (NASDAQ). Prior to Celldex, Robert was Director of Technology Licensing at the Ludwig Institute for Cancer Research, a leading independent research organisation conducting translational research in cancer immunology.
Research Interest
Pharmaceutics
